Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hedgehog Proteins | 12 | 2026 | 54 | 3.840 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2024 | 139 | 1.330 |
Why?
|
| Pyridines | 2 | 2024 | 139 | 1.300 |
Why?
|
| Pyrimidines | 2 | 2024 | 139 | 1.280 |
Why?
|
| Ethanol | 5 | 2026 | 224 | 1.220 |
Why?
|
| High-Throughput Screening Assays | 4 | 2021 | 74 | 1.080 |
Why?
|
| Signal Transduction | 10 | 2026 | 2157 | 1.060 |
Why?
|
| Heparin | 2 | 2024 | 40 | 0.970 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2026 | 6 | 0.960 |
Why?
|
| Antineoplastic Agents | 6 | 2024 | 1019 | 0.860 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 62 | 0.830 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 127 | 0.800 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2022 | 192 | 0.760 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2021 | 28 | 0.680 |
Why?
|
| Mice | 11 | 2026 | 6644 | 0.550 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2017 | 3 | 0.550 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 15 | 0.540 |
Why?
|
| Polydactyly | 1 | 2017 | 1 | 0.520 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 41 | 0.520 |
Why?
|
| Thiazoles | 1 | 2017 | 76 | 0.520 |
Why?
|
| Cyclohexylamines | 1 | 2017 | 14 | 0.520 |
Why?
|
| Thiophenes | 1 | 2017 | 32 | 0.510 |
Why?
|
| Drug Discovery | 1 | 2017 | 108 | 0.490 |
Why?
|
| Animals | 16 | 2026 | 16992 | 0.470 |
Why?
|
| Photochemical Processes | 1 | 2014 | 19 | 0.440 |
Why?
|
| Molecular Probes | 1 | 2014 | 23 | 0.440 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 24 | 0.440 |
Why?
|
| Humans | 22 | 2026 | 43102 | 0.410 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 148 | 0.400 |
Why?
|
| Harmine | 2 | 2024 | 4 | 0.400 |
Why?
|
| Quinazolines | 1 | 2013 | 38 | 0.390 |
Why?
|
| Cell Proliferation | 7 | 2023 | 1455 | 0.390 |
Why?
|
| Pregnancy | 4 | 2026 | 1772 | 0.390 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 2676 | 0.370 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2010 | 8 | 0.330 |
Why?
|
| Baculoviridae | 1 | 2010 | 12 | 0.330 |
Why?
|
| Spodoptera | 1 | 2010 | 16 | 0.330 |
Why?
|
| Cell Line | 4 | 2024 | 1410 | 0.330 |
Why?
|
| Female | 15 | 2026 | 24698 | 0.330 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 314 | 0.310 |
Why?
|
| Neoplasms | 1 | 2021 | 1377 | 0.310 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 140 | 0.300 |
Why?
|
| Enzymes | 1 | 2009 | 35 | 0.290 |
Why?
|
| Biological Assay | 1 | 2009 | 63 | 0.290 |
Why?
|
| Spermatozoa | 1 | 2010 | 214 | 0.290 |
Why?
|
| Protein Binding | 2 | 2024 | 1082 | 0.270 |
Why?
|
| Cell Survival | 4 | 2024 | 945 | 0.240 |
Why?
|
| North Carolina | 1 | 2026 | 127 | 0.230 |
Why?
|
| Ferrous Compounds | 1 | 2024 | 22 | 0.220 |
Why?
|
| Embryo, Nonmammalian | 2 | 2022 | 59 | 0.220 |
Why?
|
| NIH 3T3 Cells | 1 | 2024 | 64 | 0.210 |
Why?
|
| Glioblastoma | 1 | 2024 | 74 | 0.200 |
Why?
|
| Zebrafish | 2 | 2022 | 146 | 0.200 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2020 | 41 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 15 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2022 | 19 | 0.180 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 1180 | 0.180 |
Why?
|
| Socioeconomic Factors | 1 | 2026 | 1234 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 92 | 0.170 |
Why?
|
| Carbolines | 1 | 2021 | 17 | 0.170 |
Why?
|
| Monoamine Oxidase | 1 | 2021 | 37 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2020 | 17 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1723 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 36 | 0.160 |
Why?
|
| Central Nervous System Depressants | 1 | 2020 | 42 | 0.160 |
Why?
|
| Drug Combinations | 1 | 2020 | 104 | 0.160 |
Why?
|
| Neurogenesis | 1 | 2020 | 63 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 347 | 0.160 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 55 | 0.160 |
Why?
|
| Annexin A6 | 1 | 2019 | 17 | 0.150 |
Why?
|
| Cannabinoids | 1 | 2019 | 73 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 307 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2019 | 986 | 0.140 |
Why?
|
| Esophagus | 1 | 2018 | 42 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 51 | 0.140 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2017 | 10 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2017 | 158 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2017 | 168 | 0.130 |
Why?
|
| Hand Deformities | 1 | 2017 | 1 | 0.130 |
Why?
|
| Limb Buds | 1 | 2017 | 3 | 0.130 |
Why?
|
| Thumb | 1 | 2017 | 3 | 0.130 |
Why?
|
| Extremities | 1 | 2017 | 20 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2017 | 25 | 0.130 |
Why?
|
| Caspases | 1 | 2017 | 148 | 0.130 |
Why?
|
| Carcinogens, Environmental | 1 | 2017 | 35 | 0.130 |
Why?
|
| Benzhydryl Compounds | 1 | 2017 | 50 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 228 | 0.120 |
Why?
|
| Phenols | 1 | 2017 | 107 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 161 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 968 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 671 | 0.120 |
Why?
|
| Mutation | 2 | 2017 | 1177 | 0.110 |
Why?
|
| Benzophenones | 1 | 2014 | 11 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 1869 | 0.110 |
Why?
|
| Aged | 1 | 2026 | 8214 | 0.100 |
Why?
|
| Hepatic Stellate Cells | 1 | 2012 | 7 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 157 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2017 | 735 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2003 | 192 | 0.090 |
Why?
|
| Oxides | 1 | 2012 | 100 | 0.090 |
Why?
|
| Arsenicals | 1 | 2012 | 87 | 0.090 |
Why?
|
| Adult | 2 | 2026 | 13872 | 0.080 |
Why?
|
| Middle Aged | 1 | 2026 | 12222 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 139 | 0.080 |
Why?
|
| Apoptosis | 1 | 2017 | 1568 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 115 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 280 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 518 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2009 | 35 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 159 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 100 | 0.070 |
Why?
|
| Methyltransferases | 1 | 2009 | 68 | 0.070 |
Why?
|
| Gene Expression | 3 | 2020 | 701 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1542 | 0.070 |
Why?
|
| Spheroids, Cellular | 2 | 2017 | 37 | 0.060 |
Why?
|
| Male | 3 | 2017 | 23409 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2024 | 54 | 0.050 |
Why?
|
| Coturnix | 1 | 2003 | 2 | 0.050 |
Why?
|
| Pyrimethamine | 1 | 2023 | 10 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 39 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 32 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 506 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 17 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2002 | 29 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 443 | 0.040 |
Why?
|
| PubMed | 1 | 2020 | 5 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2020 | 17 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 15 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 518 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 31 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 138 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 293 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2003 | 638 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2020 | 49 | 0.040 |
Why?
|
| Pyridones | 1 | 2020 | 50 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 861 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 173 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 259 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 220 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 925 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 2017 | 2 | 0.030 |
Why?
|
| Drug Synergism | 2 | 2012 | 195 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 373 | 0.030 |
Why?
|
| Teratogens | 1 | 2017 | 8 | 0.030 |
Why?
|
| Disulfiram | 1 | 2017 | 2 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 25 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 110 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2020 | 457 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1081 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 98 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 152 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 121 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 508 | 0.030 |
Why?
|
| Copper | 1 | 2017 | 134 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 358 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1151 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 3994 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 734 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 523 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 2012 | 2 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 18 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 16 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2012 | 29 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 63 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 47 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 99 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 68 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 166 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 462 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 652 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 1003 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 163 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 883 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 224 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1857 | 0.020 |
Why?
|
| Epithelium | 1 | 2003 | 78 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 238 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 36 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 37 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2002 | 77 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 145 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 146 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 311 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 665 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 1154 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 561 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 1621 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1271 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 1001 | 0.010 |
Why?
|